March 25 (Reuters) - Array Biopharma Inc :
* Piper Jaffray raises to overweight from neutral; target price to $7 from $4
For a summary of rating and price target changes on U.S. companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .1568
For a summary of rating and price target changes on Canadian companies:
Reuters Eikon users, click on
Reuters 3000Xtra users, double-click
Reuters Station users, click .4899
((nyc.equities.newsroom@reuters.com); (Reuters Messaging: saqib.ahmed.thomsonreuters.com@reuters.net) ((Bangalore Newsroom +91 80 4135 5800; within U.S. +1 646 223 8780))
0 comments:
Post a Comment